Borderline personality disorder and impulsive-aggression: The role for divalproex sodium treatment

Psychiatric Annals

Volumn 26, Issue 7 SUPPL., 1996, Pages

  Hollander, Eric ^a   Grossman, Robert ^a   Stein, Dan J ^b   Kwon, Jee ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21344461809     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19960702-11     Document Type: Article

References (42)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
2. Widiger TA, Frances AJ. Epidemiology, diagnosis, and comorbidity of borderline personality disorder. In: Tasman A, Hales RE, Frances AJ, eds. Review of Psychiatry. Vol 8. Washington, DC: American Psychiatric Press; 1989:8-24.
3. Stone M. Borderline personality disorder: course of illness. In: Clarkin JF, Marziali E, Munroe-Blum H, eds. Borderline Personality Disorder: Clinical and Empirical Perspectives. New York, NY: Guilford Press; 1992.
4. Kernberg OF. Borderline Conditions and Pathological Narcissism. New York, NY: Jason Aronson; 1975.
5. Linehan MM. Cognitive-Behavioral Treatment of Borderline Personality Disorder. New York, NY: Guilford Press; 1993.
6. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry. 1988;45;111-119.
7. Stein DJ, Hollander E, Liebowitz MR. Neurobiology of impulsivity and the impulse control disorders. J Neuropsychiatry Clin Neurosci. 1993;5:9-17.
8. Siever LJ, Davis KL. A psychobiological perspective on the personality disorders. Am J Psychiatry. 1991;148: 1647-1658.
9. Hollander E, Stein DJ. Impulsivity and Aggression. Chichester, United Kingdom: Wiley & Sons; 1995.
10. Hollander E, Wong CM. Obsessive compulsive spectrum disorders: an introduction. J Clin Psychiatry. 1995; 56(suppl 4):S3-S6.
11. Mak M, de Koning PK, Mos J, Olivier B. Preclinical and clinical studies on the role of 5-HT receptors in aggression. In: Hollander E, Stein DJ, eds. Impulsivity and Aggression. Chichester, United Kingdom: Wiley & Sons; 1995.
12. Kravitz HM, Fawcett J. Carbamazepine in the treatment of affective disorders. Medical Science Research. 1987;15:1-8.
13. Blumer D, Heibronn M, Himmelhoch J. Indications for carbamazepine in mental illness: atypical psychiatric disorder or temporal lobe syndrome? Compr Psychiatry. 1988;29:108-122.
14. Mattes J. Comparative effectiveness of carbamazepine and propranolol for rage outbursts. J Neuropsychiatry Clin Neurosci. 1990;2:159-164.
15. Barratt ES, Kent TA, Bryant SG, et al. A controlled trial of phenytoin in impulsive aggression. J Clin Psychopharmacol. 1991;11:388-389. Letter.
16. McElroy SL, Keck PE Jr, Pope HG Jr. Sodium valproate: its use in primary psychiatric disorders. J Clin Psychopharmacol. 1987:7:16-24.
17. Jacobsen FM. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J Clin Psychiatry. 1993;54:229-234.
18. Deltito JA. The effect of valproate on bipolar spectrum temperamental disorders. J Clin Psychiatry. 1993;54:300-304.
19. Schaff MR, Fawcett J, Zajecka JM. Divalproex sodium in the treatment of refractory affective disorders. J Clin Psychiatry. 1993;54:380-384.
20. Akiskal HS. Sub-affective disorders: dysthymic, cyclothymic and bipolar II disorders in the borderline realm. Psychiatr Clin North Am. 1981;4:25-46.
21. Levitt AJ, Joffe RT, Ennis J, et al. The prevalence of cyclothymia in borderline personality disorder. J Clin Psychiatry. 1990;51:335-339.
22. Fesler FA. Valproate in combat-related posttraumatic stress disorder. J Clin Psychiatry. 1991;52:361-364.
23. Gunderson JG, Sabo AN. The phenomenological and conceptual interface between borderline personality disorder and PTSD. Am J Psychiatry. 1993;150:19-27.
24. Giakas WJ, Seibyl JP, Mazure CM. Valproate in the treatment of temper outbursts. J Clin Psychiatry. 1990;51:525. Letter.
25. Hasan MY, Sewell RDE, Nicholls PJ. Does the anticonvulsant agent sodium valproate display behaviorally selective anti-offensive activity? J Pharm Pharmacol. 1990 42(suppl):185. Abstract.
26. Keck PE Jr, McElroy SL, Friedman LM. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol. 1992;12(suppl 1):36-41.
27. Pies R, Adler DA, Ehrenberg BL. Sleep disorders and depression with atypical features: response to valproate. J Clin Psychopharmacol. 1989;9:352-357.
28. Roy-Byrne PP, Ward NG, Donnelly PJ. Valproate in anxiety and withdrawal syndromes. J Clin Psychiatry. 1989; 50(suppl 3):S44-S48.
29. Andrulonis PA, Glueck BC, Stroebel CF, et al. Organic brain dysfunction and the borderline syndrome. Psychiatr Clin North Am. 1981;4:47-66.
30. Cherkasky S, Hollander E. Neuropsychiatric aspects of agression and impulsivity. In: Yudofsky S, Hales R, eds. American Psychiatric Press Textbook of Neuropsychiatry. Washington, DC: American Psychiatric Press; 1996. In press.
31. Cowdry RW, Pickar D, Davies R. Symptoms and EEG findings in the borderline syndrome. Int J Psychiatr Med. 1985;15:201-211.
32. Stein DJ, Hollander E, Cohen L, et al. Neuropsychiatric impairment in impulsive personality disorders. Psychiatry Res. 1993;48:257-266.
33. Stein DJ, Towey J, Hollander E. Neuropsychiatry of impulsivity and aggression. In: Hollander E, Stein DJ, eds. Impulsivity and Aggression. New York, NY: John Wiley & Sons; 1995.
34. Prichep LS, Mas F, Hollander E, et al. Quantitative electroencephalographic subtyping of obsessive-compulsive disorder. Psychiatry Res. 1993;50:25-32.
35. Hollander E, DeCaria CM, Saoud JB, Klein DF, Liebowitz MR. In reply. Neurological soft signs in obsessive-compulsive disorder. Arch Gen Psychiatry. 1991;48:278-279.
36. Stein DJ, Simeon D, Frenkel M, Islam MN, Hollander E. An open trial of valproate in borderline personality disorder. J Clin Psychiatry. 1995;56:506-510.
37. Albright PS, Burnham WM. Development of a new pharmacological seizure model: effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat. Epilepsia. 1980;21:681-689.
38. Post RM. Introduction: emerging perspectives on valproate in affective disorders. J Clin Psychiatry. 1989; 50(suppl 3):S3-S9.
39. Markovitz P. Pharmacotherapy of impulsivity, aggression, and related disorders. In: Hollander E, Stein DJ, eds. Impulsivity and Aggression. New York, NY: John Wiley & Sons; 1995.
40. Coccaro EF, Siever LJ, Klar H, et al. Serotonergic studies in affective and personality disorder patients: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry. 1989;46:587-599.
41. Hollander E, Stein DJ, DeCaria CM, et al. Serotonergic sensitivity in borderline personality disorder: preliminary findings. Am J Psychiatry. 1994;151:277-280.
42. Shukla GS. Combined lithium and valproate treatment and subsequent withdrawal: serotonergic mechanism of their interaction in discrete brain regions. Prog Neuropsychopharm Biol Psychiatr. 1985;9:153-156.